| Authors: |
Ebara S; Department of Biological Sciences, Faculty of Science, Ibaraki University, Bunkyo 2-1-1, Mito, Ibaraki, 310-8512, Japan; Chordia Therapeutics Inc., Kanagawa, 251-0012, Japan., Yoshida M; Chordia Therapeutics Inc., Kanagawa, 251-0012, Japan., Yamakawa H; Department of Biological Sciences, Faculty of Science, Ibaraki University, Bunkyo 2-1-1, Mito, Ibaraki, 310-8512, Japan; Chordia Therapeutics Inc., Kanagawa, 251-0012, Japan., Shimokawa K; Chordia Therapeutics Inc., Kanagawa, 251-0012, Japan., Inoue Y; Department of Cell Signaling, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, 467-8603, Japan., Tauchi H; Department of Biological Sciences, Faculty of Science, Ibaraki University, Bunkyo 2-1-1, Mito, Ibaraki, 310-8512, Japan. Electronic address: hiroshi.tauchi.sci@vc.ibaraki.ac.jp., Morishita D; Chordia Therapeutics Inc., Kanagawa, 251-0012, Japan. Electronic address: daisuke.morishita.phd@gmail.com. |